Bringing the fundamentals into focus…
Back to Kiniksa Pharmaceuticals International, plc
How Kiniksa Pharmaceuticals International, plc stacks up
KNSA · against 201 other Healthcare companies of similar size
Valuation
40/ 100
Below the middle of the pack.
Ranked #139 of 202 · scores higher than 30% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 40–49, including KNSA · Click a bar to see the companies
Why valuation scores 40?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield, but weaker EBITDA yield than most Healthcare peers.
- less operating profit (EBITDA) for the company's total value: weaker than 63% of peers. EBITDA yield: 1.5% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 1.0% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 64% of peers. Free cash flow yield: 2.4% vs peer median 0.0%
Metric by metric
Position: dot = KNSA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KNSA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 199 reported | 1.1% | 2.4% | 38% | 30% | |
| EBITDA yieldHigher is better · 201 reported | 1.5% | 4.6% | 30% | 50% | |
| Free cash flow yieldHigher is better · 120 reported | 2.5% | 1.1% | 62% | 20% | |
| Book yieldHigher is better · 200 reported | 9.0% | 22.6% | 21% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around KNSA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 133 | 10.8B USD | 41 | 41 | |
| 133 | 12.6B USD | 41 | 65 | |
| 139 | 29.2B CNY (≈$4.1B) | 40 | 42 | |
| 139 | 32.6B HKD (≈$4.2B) | 40 | 60 | |
| 139 | 7.3B USD | 40 | 74 | |
| 139 | 62.5B SEK (≈$6.3B) | 40 | 60 | |
| 143 | 9.4B USD | 39 | 70 | |
| 144 | 4.0B USD | 38 | 56 | |
| 144 | 20.0B AUD (≈$13.2B) | 38 | 77 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score